KROSNEUTRAL

KROS Gross Margin Analysis

-9.8%

Higher than 7% of Healthcare sector peers

Updated 2508h ago·SEC filings & market data

Key Takeaway

KROS (KROS) has a Gross Margin of -9.8% as of May 2026.

Sector Performance

7th percentile

KROS

-9.8%

Sector Median

68.3%

Sector Avg

-55.4%

Prior Period

-4.1%(May 2026)

↓ Declining
📊

Deep Analysis

KROS (KROS) has a Gross Margin of -9.8% as of May 2026.

This places KROS in the 7th percentile of the Healthcare sector, which has a median Gross Margin of 68.3% and a sector average of -55.4%. KROS's Gross Margin is 114.3% below the sector median, a significant divergence that warrants closer examination. In context: Gross margin reveals pricing power and cost structure. Software companies often sustain 70–80%; manufacturers typically 30–50%. Expansion is a bullish signal.

Frequently Asked Questions

What does the Gross Margin tell investors about KROS?

Gross margin reveals pricing power and cost structure. Software companies often sustain 70–80%; manufacturers typically 30–50%. Expansion is a bullish signal.

How is the Gross Margin calculated?

Gross Margin is calculated as: Gross Profit / Revenue.

How does KROS's Gross Margin compare to its sector?

KROS's Gross Margin of -9.8% compares to a Healthcare sector median of 68.3%, placing it in the 7th percentile.

Who are KROS's closest peers by Gross Margin?

The closest Healthcare peers by Gross Margin include: AMGN (68.2%), BLUE (68.4%), TECH (66.9%), EXAS (70.1%), ALGN (70.8%).

The Formula

Gross Profit / Revenue

Why It Matters

Gross margin reveals pricing power and cost structure. Software companies often sustain 70–80%; manufacturers typically 30–50%. Expansion is a bullish signal.

Advertisement

Master KROS's Valuation

Get the complete institutional research report covering all fundamental and technical metrics.

View full KROS research report

Free account — no credit card

KROS

-9.8%

Sector Median

68.3%

Sector Avg

-55.4%

How KROS's Gross Margin compares to sector peers.

Not financial advice. Research tool only. Data may be delayed.